Literature DB >> 30844036

Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases.

Daniel N Cagney1, Nayan Lamba1,2, Sumi Sinha3, Paul J Catalano4,5, Wenya Linda Bi6, Brian M Alexander1, Ayal A Aizer1.   

Abstract

IMPORTANCE: Neurosurgical resection represents an important management strategy for patients with large, symptomatic brain metastases and increasingly is followed by stereotactic radiation as opposed to whole-brain radiation. Whether neurosurgical resection is associated with tumor spread beyond the resection site and adjuvant stereotactic radiation field remains unknown.
OBJECTIVE: To characterize the association and incidence of pachymeningeal seeding with neurosurgical resection in patients with brain metastases treated with adjuvant stereotactic radiation. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort study of a consecutive sample of patients with newly diagnosed brain metastases managed with neurosurgical resection and stereotactic radiation (n = 318) vs radiation alone (n = 870) between 2001 and 2015. MAIN OUTCOMES AND MEASURES: Incidence of pachymeningeal seeding (dural and/or outer arachnoid) and leptomeningeal disease in patients treated with neurosurgical resection and stereotactic radiation vs radiation alone and the risk factors and outcomes associated with pachymeningeal seeding in patients treated with neurosurgical resection followed by stereotactic radiation.
RESULTS: In 1188 patients with newly diagnosed brain metastases, 133 men and 185 women (mean [SD] age, 58.9 [11.5] years) underwent neurosurgical resection. Resection was found to be associated with pachymeningeal seeding (36 of 318 patients vs 0 of 870 patients; P < .001) but not leptomeningeal disease (hazard ratio [HR], 1.14; 95% CI, 0.73-1.77; P = .56). In total, 36 (8.4%) of 428 operations were complicated by pachymeningeal seeding, with a higher incidence noted with resection of previously irradiated vs unirradiated metastases (HR, 2.39; 95% CI, 1.25-4.57; P = .008). Patients with pachymeningeal seeding had relatively low rates of subsequent development of new brain metastases and leptomeningeal disease (8 [16%] of 51 and 6 [13%] of 48, respectively). Among patients with pachymeningeal seeding, neurologic death primarily owing to progressive pachymeningeal disease accounted for 26 (72%) of 36 deaths, but when treated with salvage radiation, 49.1% of patients survived 1 year or longer. CONCLUSIONS AND RELEVANCE: In the era of omission of adjuvant whole-brain radiation after neurosurgical resection, pachymeningeal seeding beyond the stereotactic radiation field represents a notable oncologic event that often proves difficult to salvage. However, in some patients, disease control can be achieved with radiotherapeutic approaches.

Entities:  

Mesh:

Year:  2019        PMID: 30844036      PMCID: PMC6512273          DOI: 10.1001/jamaoncol.2018.7204

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


  20 in total

1.  Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group.

Authors:  A Aupérin; R Arriagada; J P Pignon; C Le Péchoux; A Gregor; R J Stephens; P E Kristjansen; B E Johnson; H Ueoka; H Wagner; J Aisner
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

2.  A randomized trial of surgery in the treatment of single metastases to the brain.

Authors:  R A Patchell; P A Tibbs; J W Walsh; R J Dempsey; Y Maruyama; R J Kryscio; W R Markesbery; J S Macdonald; B Young
Journal:  N Engl J Med       Date:  1990-02-22       Impact factor: 91.245

3.  Stereotactic radiosurgery for focal leptomeningeal disease in patients with brain metastases.

Authors:  Amparo Wolf; Bernadine Donahue; Joshua S Silverman; Abraham Chachoua; Jean K Lee; Douglas Kondziolka
Journal:  J Neurooncol       Date:  2017-05-23       Impact factor: 4.130

4.  Stereotactic radiotherapy of the tumor bed compared to whole brain radiotherapy after surgery of single brain metastasis: Results from a randomized trial.

Authors:  Lucyna Kępka; Dobromira Tyc-Szczepaniak; Krzysztof Bujko; Marta Olszyna-Serementa; Wojciech Michalski; Arkadiusz Sprawka; Berenika Trąbska-Kluch; Katarzyna Komosińska; Ewa Wasilewska-Teśluk; Beata Czeremszyńska
Journal:  Radiother Oncol       Date:  2016-10-25       Impact factor: 6.280

5.  Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery.

Authors:  Matthew D Johnson; Vladimir Avkshtol; Andrew M Baschnagel; Kurt Meyer; Hong Ye; Inga S Grills; Peter Y Chen; Ann Maitz; Rick E Olson; Daniel R Pieper; Daniel J Krauss
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-11-19       Impact factor: 7.038

6.  Leptomeningeal failure in patients with breast cancer receiving stereotactic radiosurgery for brain metastases.

Authors:  Edina C Wang; Andrew J Huang; Karen E Huang; Emory R McTyre; Hui-Wen Lo; Kounosuke Watabe; Linda Metheny-Barlow; Adrian W Laxton; Stephen B Tatter; Roy E Strowd; Michael D Chan; Brandi R Page
Journal:  J Clin Neurosci       Date:  2017-05-13       Impact factor: 1.961

Review 7.  Cerebral radiation necrosis.

Authors:  Pierre Giglio; Mark R Gilbert
Journal:  Neurologist       Date:  2003-07       Impact factor: 1.398

8.  A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.

Authors:  Riccardo Soffietti; Martin Kocher; Ufuk M Abacioglu; Salvador Villa; François Fauchon; Brigitta G Baumert; Laura Fariselli; Tzahala Tzuk-Shina; Rolf-Dieter Kortmann; Christian Carrie; Mohamed Ben Hassel; Mauri Kouri; Egils Valeinis; Dirk van den Berge; Rolf-Peter Mueller; Gloria Tridello; Laurence Collette; Andrew Bottomley
Journal:  J Clin Oncol       Date:  2012-12-03       Impact factor: 44.544

9.  Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial.

Authors:  R A Patchell; P A Tibbs; W F Regine; R J Dempsey; M Mohiuddin; R J Kryscio; W R Markesbery; K A Foon; B Young
Journal:  JAMA       Date:  1998-11-04       Impact factor: 56.272

10.  Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

Authors:  Daniel N Cagney; Allison M Martin; Paul J Catalano; Amanda J Redig; Nancy U Lin; Eudocia Q Lee; Patrick Y Wen; Ian F Dunn; Wenya Linda Bi; Stephanie E Weiss; Daphne A Haas-Kogan; Brian M Alexander; Ayal A Aizer
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

View more
  23 in total

1.  Nodular Leptomeningeal Disease After Surgery for a Brain Metastasis - Should We Be Concerned?

Authors:  Michael A Vogelbaum; H Michael Yu
Journal:  Neuro Oncol       Date:  2019-05-03       Impact factor: 12.300

2.  Leptomeningeal disease following local brain irradiation: a new frontier.

Authors:  Daniel M Trifiletti; Paul D Brown
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

3.  Predictors of leptomeningeal disease following hypofractionated stereotactic radiotherapy for intact and resected brain metastases.

Authors:  Timothy K Nguyen; Arjun Sahgal; Jay Detsky; Eshetu G Atenafu; Sten Myrehaug; Chia-Lin Tseng; Zain Husain; Chris Heyn; Pejman Maralani; Mark Ruschin; James Perry; Hany Soliman
Journal:  Neuro Oncol       Date:  2020-01-11       Impact factor: 12.300

4.  Focal Leptomeningeal Disease with Perivascular Invasion in EGFR-Mutant Non-Small-Cell Lung Cancer.

Authors:  A Dasgupta; F Y Moraes; S Rawal; P Diamandis; D B Shultz
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

Review 5.  Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions.

Authors:  Ayal A Aizer; Nayan Lamba; Manmeet S Ahluwalia; Kenneth Aldape; Adrienne Boire; Priscilla K Brastianos; Paul D Brown; D Ross Camidge; Veronica L Chiang; Michael A Davies; Leland S Hu; Raymond Y Huang; Timothy Kaufmann; Priya Kumthekar; Keng Lam; Eudocia Q Lee; Nancy U Lin; Minesh Mehta; Michael Parsons; David A Reardon; Jason Sheehan; Riccardo Soffietti; Hussein Tawbi; Michael Weller; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2022-10-03       Impact factor: 13.029

6.  Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis.

Authors:  Desmond A Brown; Victor M Lu; Benjamin T Himes; Terry C Burns; Alfredo Quiñones-Hinojosa; Kaisorn L Chaichana; Ian F Parney
Journal:  Clin Exp Metastasis       Date:  2020-01-16       Impact factor: 5.150

7.  The relevance of surgical status in nodular leptomeningeal metastasis patient outcomes.

Authors:  Matthew Dankner; Sarah M Maritan
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 12.300

8.  Prognostic factors in leptomeningeal metastases.

Authors:  Emilie Le Rhun; Patrick Devos; Johannes Weller; Katharina Seystahl; Francesca Mo; Anette Compter; Anna S Berghoff; Joost L M Jongen; Fabian Wolpert; Roberta Rudà; Dieta Brandsma; Martin van den Bent; Matthias Preusser; Ulrich Herrlinger; Michael Weller
Journal:  Neuro Oncol       Date:  2021-07-01       Impact factor: 12.300

Review 9.  Advances in Diagnosis and Treatment for Leptomeningeal Disease in Melanoma.

Authors:  Yolanda Piña; Sirisha Yadugiri; Debra N Yeboa; Sherise D Ferguson; Peter A Forsyth; Isabella C Glitza Oliva
Journal:  Curr Oncol Rep       Date:  2022-01-20       Impact factor: 5.075

10.  Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control.

Authors:  Evan D Bander; Melissa Yuan; Anne S Reiner; Katherine S Panageas; Åse M Ballangrud; Cameron W Brennan; Kathryn Beal; Viviane Tabar; Nelson S Moss
Journal:  Neurooncol Pract       Date:  2021-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.